Predictable and effective sedation and analgesia you can count on every time
DORMOSEDAN is an a2 adrenoceptor agonist that provides non-narcotic sedation and analgesia that can be used safely in horses for a variety of minor surgical and diagnostic procedures. The greater a2 selectivity of DORMOSEDAN allows it to bind specifically to a2 adrenoceptors to produce predictable and effective sedation and analgesia.
Moens Y, Lanz F, Doherr MG, Schatzmann U. A comparison of the
antinociceptive effects of xylazine, detomidine and romifidine on experimental pain in horses. Vet Anesth Analg 2003;30(3);183-190.
Kamerling SG, Winter MT, et. al. Objective assessment of detomidine-induced analgesia and sedation in the horse. Eur J Pharmacol 1988;151;1-8.
Jochle W, Baker GJ, et. al. Comparison of detomidine, butorphanol, flunixin meglumine and xylazine in clinical cases of equine colic. Eq Vet J 1989;7;111-116.
Virtanen R, Savola V, et.al. Characterization of the selectivity, specificity and potency of medetomidine as an a2 adrenocepter agonist. Eur J Pharmacol 1988;150:9–14.
Daunt D. Detomidine in equine sedation and analgesia. Comp Cont Edu 1995;17:1405–1411.
IMPORTANT SAFETY INFORMATION As with other a2 -agonists, bradycardia and partial AV and SA blocks can occur with decreased respiratory rates. Occasional reports of anaphylactic-like reactions have been observed. The use of epinephrine should be avoided since epinephrine may potentiate the effects of a2 -agonists. full prescribing information to find out more.